Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20070029HPVENSG00000101868.13protein_codingPOLA1NoNo5422A6NMQ1
P09884
TVIS20028064HPVENSG00000101868.13protein_codingPOLA1NoNo5422A6NMQ1
P09884
TVIS20069518HPVENSG00000101868.13protein_codingPOLA1NoNo5422A6NMQ1
P09884
TVIS20030467HPVENSG00000101868.13protein_codingPOLA1NoNo5422A6NMQ1
P09884
TVIS20028056HPVENSG00000101868.13protein_codingPOLA1NoNo5422A6NMQ1
P09884
TVIS20069519HPVENSG00000101868.13protein_codingPOLA1NoNo5422A6NMQ1
P09884
TVIS20064299HPVENSG00000101868.13protein_codingPOLA1NoNo5422A6NMQ1
P09884
TVIS20028053HPVENSG00000101868.13protein_codingPOLA1NoNo5422A6NMQ1
P09884
TVIS20069520HPVENSG00000101868.13protein_codingPOLA1NoNo5422A6NMQ1
P09884
TVIS20064235HPVENSG00000101868.13protein_codingPOLA1NoNo5422A6NMQ1
P09884
TCGA Plot Options
Drug Information
GenePOLA1
DrugBank IDDB01280
Drug NameNelarabine
Target IDBE0000546
UniProt IDP09884
Regulation Typeinhibitor
PubMed IDs91427; 18035189; 18473971; 12750168
CitationsOno K, Ohashi A, Yamamoto A, Matsukage A, Takahasi T, Saneyoshi M, Ueda T: Inhibitory effects of 9-beta-D-arabinofuranosylguanine 5'-triphosphate and 9-beta-D-arabinofuranosyladenine 5'-triphosphate on DNA polymerases from murine cells and oncornavirus. Cancer Res. 1979 Nov;39(11):4673-80.@@Buie LW, Epstein SS, Lindley CM: Nelarabine: a novel purine antimetabolite antineoplastic agent. Clin Ther. 2007 Sep;29(9):1887-99.@@Curbo S, Karlsson A: Nelarabine: a new purine analog in the treatment of hematologic malignancies. Rev Recent Clin Trials. 2006 Sep;1(3):185-92.@@Rodriguez CO Jr, Stellrecht CM, Gandhi V: Mechanisms for T-cell selective cytotoxicity of arabinosylguanine. Blood. 2003 Sep 1;102(5):1842-8. Epub 2003 May 15.
GroupsApproved; Investigational
Direct ClassificationPurine nucleosides
SMILESCOC1=NC(N)=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O
Pathways
PharmGKBPA164752425
ChEMBLCHEMBL1201112